Remi Nout currently heads the Department of Radiotherapy at the Erasmus Medical Center, Rotterdam, The Netherlands. He is well known for his role in PORTEC trials investigating the role of radiotherapy in endometrial cancer. He has actively contributed to the coordinator role in the EMBRACE group, which focuses on the role of image-guided radiotherapy and brachytherapy for cervical cancer. He co-led a multicenter international BIOEMBRACE study that tested the impact of biomarkers in cervical cancer. He is principal investigator of new studies that combine image-guided adaptive brachytherapy with immunotherapy and targeted therapies in high-risk cervical cancer, the EMBRAVE study in primary and recurrent vaginal cancers, and the RAPID prospective study in low-risk cervical cancer, which will test the role of de-escalation in cervical cancer. He co-leads RetroCOSMOS, an international registry for recurrent metastatic cervical cancer, with a focus on re-irradiation. He is currently a co-chair of the ESTRO Gynec Focus group and chair of the Dutch Gynaecological Oncology Group (DGOG) and Gynecological Cancer Inter Group – Cervical Cancer Research Network (GCIG-CCRN); radiotherapy representative in the European Society of Gynaecological Oncology (ESGO) council, and has been involved in European multidisciplinary guidelines for cervical, endometrial, and vaginal cancers. He has actively contributed to international education and training as co-course director of the ESTRO Gyn course and through collaborations within AROI-ESTRO, IGCS, and CCRN training programs.

Supriya Chopra is a Professor in Radiation Oncology at ACTREC, Tata Memorial Centre, India. She is well known for her work in cervical cancer. Her work within the phase III trial PARCER lead to IG-IMRT becoming the standard of care. She is Principal Investigator for Phase III RCT that tested protease inhibitor (Nelfinavir Mesylate) with Image guided IMRT and MR based BT in cervical cancer (NELCER). Presently she has ongoing phase III trials testing radiotherapy fractionation in palliative RT and NRF-2 pathway inhibitors for late adverse event reduction after pelvic RT. Her other contributions include work in MRI and PET image guided brachytherapy in post surgical recurrent cervical cancers and reirradiation. She has successfully lead global research projects with different research groups BIOEMBRACE (translational research in cervix cancer), RETROCOSMOS (recurrent/metastatic cervical cancer). She has also been involved in IAEA image guided brachytherapy implementation projects and needs assessment of 14 countries. She served as lead author on NCG India Cervix cancer guidelines and has spearheaded the conceptual framework for national transition for Image guided Brachytherapy and intensity modulated RT. MOSES late adverse event scoring system which is validated on leading gynecological cancer study databases was developed by her research group. She is focussing on developing framework for TCP, NTCP modelling for postoperative RT and Reirradiation. She has an active clinical program that tests Spatially Fractionated RT and Proton Therapy for Gynecological Cancers. She was Associate Editor for Gyn section of Red Journal (IJROBP). She is presently Associate Editor for Journal of Clinical Oncology-Global Oncology and Gynecological Cancer Section Editor for the Green Journal. She serves as Course director for AROI ESTRO teaching course in Gynecological Cancers and brachytherapy training mentor within IGCS. She serves as Chair of research commitee for Federation of Asian Radiation Oncologists and is Chair Elect (2028-2031) for GEC ESTRO Gyn Working group.

Kari Tanderup is a Professor in Medical Physics at Aarhus University and Danish Centre for Particle Therapy, Aarhus, Denmark. Her research interests include gynecological cancer radiotherapy and environmental sustainability. Within these topics, she authored 200+ papers and supervised 15+ Ph.D. students. During the last 15 years, she has actively contributed to various activities of the European Society of Radiation Oncology (ESTRO). This includes the ESTRO board member (2019-2025), chair of ESTRO Green Task Force (2023–), chair of GEC ESTRO gyn WG (2015-2025), co-chair of ESTRO gyn focus group (2024–), and course director of ESTRO and AROI/ESTRO gyn teaching courses. She has contributed to international guidelines on cervical cancer radiotherapy through the ESTRO society and has contributed to the coordination of prospective clinical studies for cervical cancer patients (EMBRACE I and II). Within the field of environmental sustainability, she is currently coordinating international efforts in the context of radiotherapy to facilitate and promote research and dissemination. She is engaged in research projects that assess the carbon footprints of proton therapy and brachytherapy. She is co-chairing the Green ESTRO network, which arranges webinars and conferences.